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Abstract
 
Natural killer T (NKT) cells have been implicated in diverse immune responses ranging from
suppression of autoimmunity to tumor rejection. Thymus-dependent NKT cells are positively
 
selected by the major histocompatibility complex class I–like molecule CD1d, but the molecular
events downstream of CD1d are still poorly understood. Here, we show that distinct members of
the Rel/nuclear factor (NF)-
 
 
 
B family of transcription factors were required in both hemato-
poietic and nonhematopoietic cells for normal development of thymic NKT cells. Activation
of NF-
 
 
 
B via the classical I
 
 
 
B
 
 
 
-regulated pathway was required in a cell autonomous manner
for the transition of NK-1.1–negative precursors that express the TCR V
 
 
 
14-J
 
 
 
18 chain to
mature NK-1.1–positive NKT cells. The Rel/NF-
 
 
 
B family member RelB, on the other
hand, had to be expressed in radiation resistant thymic stromal cells for the generation of early
 
NK-1.1–negative NKT precursors. Moreover, NF-
 
 
 
B–inducing kinase (NIK) was required for
both constitutive thymic DNA binding of RelB and the specific induction of RelB complexes in
 
vitro. Thus, distinct Rel/NF-
 
 
 
B family members in hematopoietic and nonhematopoietic cells
regulate NKT cell development with a unique requirement for NIK-mediated activation of RelB
in thymic stroma.
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Introduction
 
NKT cells represent a subset of mature T lymphocytes,
which are characterized by the coexpression of NK cell
surface markers and the TCR as well as high levels of cyto-
kine production, in particular IL-4 and IFN-
 
 
 
. NKT cells
 
are most frequent in thymus, bone marrow (BM),
 
*
 
 spleen,
and liver and represent a smaller proportion of T cells in
lymph nodes, blood, and lung. In mouse thymus, NKT
 
cells are either CD4
 
 
 
CD8
 
 
 
 or CD4
 
 
 
CD8
 
 
 
 and represent
0.3–0.8% of total thymocytes and up to 20% of the mature
heat stable antigen (HSA)
 
neg-low
 
 thymocyte fraction (for re-
views, see references 1–3). Thymus-dependent NKT cells
are positively selected by CD1d, a nonclassical MHC class
I–like, 
 
 
 
2
 
-microglobulin-associated molecule, and they
predominantly express the invariant V
 
 
 
14-J
 
 
 
18 TCR
(4–7). These so-called V
 
 
 
14
 
i
 
 NKT cells respond to the
marine sponge-derived glycolipid 
 
 
 
-galactosyl ceramide
(
 
 
 
-GalCer) and can be identified by staining with 
 
 
 
-GalCer–
loaded CD1d tetramers (8–10). Other populations of NKT
 
cells, defined by NK-1.1 and TCR expression, do not ex-
 
press the V
 
 
 
14-J
 
 
 
18 TCR and thus are unresponsive to
 
 
 
-GalCer (11, 12).
Several independent observations indicate that the re-
quirements for NKT cell and conventional TCR
 
  
 
 T
lymphocyte development are fundamentally different. First,
whereas thymic epithelial cells are the predominant cell
type for positive selection of conventional T cells, BM-
derived immature CD4
 
 
 
CD8
 
 
 
 double positive (DP) thy-
mocytes are required for the positive selection of NKT
cells (6, 13). Second, many mutations/gene deletions that
impair development of conventional T cells do not have a
severe effect on the development of NKT cells and in a few
cases the opposite is true (for a review, see reference 14).
 
The online version of this article contains supplemental material.
Address correspondence to Falk Weih, Forschungszentrum Karlsruhe,
Institute of Toxicology and Genetics, P.O. Box 3640, 76021 Karlsruhe,
Germany. Phone: 49-7247-823302; Fax: 49-7247-823354; E-mail:
falk.weih@itg.fzk.de
 
*
 
Abbreviations used in this paper:
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B–inducing kinase.T
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B
 
These observations suggest that mouse NKT cells belong to
a special lineage of T lymphocytes and that NKT precur-
sors follow the conventional developmental pathway to the
CD4
 
 
 
CD8
 
 
 
 DP thymocyte to branch off into the NKT
lineage as a result of CD1d mediated instructions given to
the V
 
 
 
14-J
 
 
 
18 TCR (1). The recent finding that NKT
cells are indeed derived from DP thymocytes (15) supports
this model, but the molecular events downstream of CD1d
selection are still poorly understood.
Gene knockout studies demonstrate that lymphotoxin
(LT) plays an important role in organogenesis and mainte-
nance of secondary lymphoid tissue microarchitecture (for
a review, see reference 16). Membrane LT signaling is de-
fective in the absence of functional nuclear factor (NF)-
 
 
 
B–inducing kinase (NIK) and NIK-deficient as well as
alymphoplasia (
 
aly/aly
 
) mice, which carry an amino acid
substitution in the COOH-terminal domain of NIK, have
similar defects in lymphoid organ development (16–19).
Interestingly, both LT signaling and NIK are required for
normal mouse NKT cell development, but dispensable for
the development of conventional T cells (20–22).
The Rel/NF-
 
 
 
B transcription factors, consisting of the
family members NF-
 
 
 
B1 (encoding p50 and its precursor
p105), NF-
 
 
 
B2 (encoding p52 and its precursor p100),
RelA (p65), RelB, and c-Rel, play an important role in
immune responses, inflammation, cell survival, and cancer
(23–25). In resting cells, NF-
 
 
 
B proteins are retained in
the cytoplasm as inactive forms via the association with
inhibitory I
 
 
 
B molecules. The classical induction of p50-
RelA NF-
 
 
 
B heterodimers involves activation of the I
 
 
 
B
kinase (IKK) complex by a wide range of stimuli, resulting
in the phosphorylation and ubiquitin-dependent degrada-
tion of I
 
 
 
B
 
 
 
. As a consequence, RelA NF-
 
 
 
B complexes
translocate to the nucleus and regulate the expression of
 
 
 
B target genes (26, 27). Recently, an alternative pathway
has been described that involves NIK/IKK
 
 
 
-mediated
phosphorylation of the inhibitory p100 precursor, its pro-
cessing to p52, and nuclear translocation of p52-RelB
heterodimers (28).
Rel/NF-
 
 
 
B proteins have essential and distinct roles in
development and function of the immune system. Similar
to LT signaling, Rel/NF-
 
 
 
B family members are required
for proper organogenesis and maintenance of secondary
lymphoid tissues (29–31). Importantly, while NF-
 
 
 
B regu-
lates specific T cell functions, such as antigen/mitogen-
induced proliferation and cytokine production, thymic de-
velopment of conventional T cells is not affected by the
targeted deletion of individual Rel/NF-
 
 
 
B family mem-
bers or the blockage of the classical NF-
 
 
 
B pathway with a
mutant nondegradable mI
 
 
 
B
 
 
 
 super-inhibitor (32).
We show here that, similar to 
 
aly/aly
 
 mice, RelB-defi-
cient animals lacked thymus-dependent V
 
 
 
14
 
i
 
 NKT cells.
Whereas RelB had to be expressed in radiation-resistant
thymic stromal cells, classical NF-
 
 
 
B was required in NKT
precursors for their maturation and expansion. We further
show that NIK regulates RelB DNA binding in vitro and
in vivo, suggesting a unique requirement for NIK-medi-
ated activation of RelB in NKT cell development.
 
Materials and Methods
 
Mice.
 
Generation of 
 
nfkb1
 
 
 
/
 
 
 
 (33), 
 
nfkb2
 
 
 
/
 
 
 
 (34), 
 
relB
 
 
 
/
 
 
 
(35), 
 
ltbr
 
 
 
/
 
 
 
 (36), 
 
tnfr1
 
 
 
/
 
  
 
(37), and mI
 
 
 
B
 
 
 
tg
 
 mice (38) has been
described previously. Alymphoplasia (
 
aly/aly
 
) (17, 19) mice were
kindly provided by Dr. Thomas Böhm, Max-Planck-Institute of
Immunobiology, Freiburg, Germany. C57BL/6-Ly-5.1 mice
were obtained from Charles River Laboratories. Adoptive BM
transfers were performed as previously described (30) and chi-
meric mice were analyzed 12–14 wk after reconstitution. All ani-
mals were housed and bred under standardized conditions with
water and food 
 
ad libitum
 
 in the SPF mouse facility of the For-
schungszentrum Karlsruhe.
 
Flow Cytometric Analyses.
 
Flow cytometry was performed us-
ing a Becton Dickinson LSR flow cytometer. Single cell suspen-
sions were washed twice with staining buffer (PBS, 2% FCS) and
incubated with Fc Block™ (clone 2.4G2). The following conju-
gated mAbs were used: anti-NK-1.1-PE (clone PK136, diluted
1:200), anti-TCR
 
 
 
-FITC (clone H57–597, diluted 1:100), anti-
CD24/HSA-Biotin (clone M1/69, diluted 1:100), anti-CD4-
FITC/Biotin (clone RM4–5, diluted 1:100), anti-CD8
 
 
 
-PE/
Biotin (clone 53–6.7, diluted 1:200), anti-CD1d-FITC (clone
1B1, diluted 1:100), anti-CD44-Biotin (clone IM7, diluted 1:100),
and anti-Ly-5.2-Biotin (clone 104, diluted 1:100). All mAbs were
from BD Biosciences. Biotinylated mAbs were detected with
Streptavidin-PerCP (BD Biosciences, diluted 1:200). Apoptotic
cells were detected by Annexin V-FITC staining according to the
manufacturer’s recommendations (Roche). Incubations were for
30 min on ice followed by two washes with staining buffer.
Staining with 
 
 
 
-GalCer–loaded CD1d tetramers was performed
as described previously (39). Data were analyzed using CELLQuest
Pro™ software (BD Biosciences).
 
Cell Culture.
 
Primary mouse embryonic fibroblasts (MEFs)
were prepared from E15.5 embryos according to standard
procedures (40), cultured in DMEM supplemented with 10%
heat-inactivated FCS, penicillin (100 U/ml), streptomycin
(100 
 
 
 
g/ml), 
 
l
 
-glutamine (2 mM), and treated with agonistic
anti-LT
 
 
 
R mAb (1 
 
 
 
g/ml clone AC.H6; gift from Dr.
Jeffrey Browning and Dr. Paul Rennert, Biogen, Cam-
bridge, MA).
 
RNA Analysis.
 
RNA extraction and quantitative RT-PCR
were performed as reported previously (30). Briefly, amplification
conditions using an MJ Research PTC-225 thermal cycler were
94
 
 
 
C for 1 min, 55
 
 
 
C for 1 min, 72
 
 
 
C for 1 min in the presence
of 1 
 
 
 
Ci [
 
 
 
-
 
32
 
P]dCTP. The linear range of amplification was de-
termined for each primer pair: V
 
 
 
14/J
 
 
 
18, 26 cycles; C
 
 
 
, 18 cy-
cles; IL-15, 29 cycles. Amplified products were separated in 6%
polyacrylamide gels. Quantifications were done with a Fujix BAS
1000 Phosphorimager. PCR primers were: V
 
 14 (GTT GTC
CGT CAG GGA GAG AA) and J 18 (CAA TCA GCT GAG
TCC CAG CT), IL-15 (TCA GCA GAT AAC CAG CCT AC
and TTT CTC CTC CAG CTC CTC AC), and C  (CAC
TGA TGT TCT GTG TGA CA and GAG GAT CTG AGA
AAT GTG ACT CCA C).
Electrophoretic Mobility Shift Assays. Whole thymus tissue ex-
tracts and nuclear extracts from fibroblasts were prepared and
electrophoretic mobility shift assays (EMSAs) were performed as
described previously (38, 41). Integrity of extracts was checked
using an Oct oligodeoxynucleotide.
Online Supplemental Material. Fig. S1 shows reduced numbers
of V 14i/NKT cells in relB /  and mI B tg mice. Thymocytes
from 3-mo-old mice were analyzed for tetramer binding and
TCR  expression by flow cytometry (lymphocyte gate). Num-
bers indicate mean values   SD from three mice. Online supple-T
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mental material is available at http://www.jem.org/cgi/content/
full/jem.20022234/DC1. 
Results
NF- B Is Essential for Normal NKT Cell Development.
To examine the role of individual Rel/NF- B subunits in
NKT cell development we analyzed mice with targeted
disruptions of RelB (relB / ), p50/NF- B1 (nfkb1 / ),
and p52/NF- B2 (nfkb2 / ) as well as transgenic mice, in
which NF- B function is inhibited in T cells by the ex-
pression of a nondegradable mutant form of the I B  mol-
ecule under the control of the T cell–specific lck proximal
promoter (mI B tg). The percentage of NK-1.1 TCR  
cells in thymus of relB /  mice was dramatically reduced
( 20-fold) compared with wild-type mice (Fig. 1 A). Thy-
mic NK-1.1 TCR   cells were also markedly reduced in
nfkb1 /  mice ( 4-fold), whereas nfkb2 /  mice showed a
milder phenotype with two- to threefold reduced NK-
1.1 TCR   cell numbers (Fig. 1 A). The observed defects
in NKT cell development in relB / , nfkb1 / , and nfkb2 / 
mice could be due to the lack of these proteins in all cells
of the thymus (including stroma) or to impaired NF- B
function in hematopoietic thymocytes that develop into
mature T cells. We therefore analyzed mI B tg mice, in
which NF- B function is blocked in Lck-expressing thy-
mocytes (38). Interestingly, the specific inhibition of NF-
 B in these cells also resulted in a  5-fold reduced NKT
cell population compared with nontransgenic littermates
(Fig. 1 B).
Since NKT cell development can still occur in the ab-
sence of the NK-1.1 marker (42), the observed reduction
of NK-1.1 TCR   cells in relB / , nfkb1 / , nfkb2 / ,
and mI B tg mice could be due to the lack of NK-1.1 ex-
pression. Expression of the V 14-J 18 chain is considered
a more stringent measure for the major population of NKT
cells in thymus (43). Semiquantitative RT-PCR analysis
revealed reduced V 14-J 18 mRNA levels in relB / ,
nfkb1 / , nfkb2 / , and mI B tg thymocytes (Fig. 1 C, and
unpublished data). Staining with  -GalCer/CD1d tetra-
mers confirmed the reduced V 14i NKT cell numbers, in-
dicating that these mice have a true defect in NKT cell de-
velopment (online supplemental Fig. S1).
Selective Loss of CD4  NKT Cells in Spleen and Bone Mar-
row of relB /  and nfkb1 /  Mice. Spleen and BM are
other major lymphoid organs where NKT cells are found.
Despite the significant reduction in thymic NKT cells, only
a moderate reduction in total NKT cell numbers was ob-
served in spleen and BM of relB / , nfkb1 / , and mI B tg
mice (unpublished data). When different peripheral
NKT cell subpopulations were analyzed thymus-depen-
dent CD4  NKT cells were clearly reduced in spleens from
relB /  (4.5-fold) and nfkb1 /  mice (threefold). Interest-
ingly, nfkb1 /  spleens showed a selective fourfold increase
in the percentage of CD8  NK-1.1  T cells, whereas this
subpopulation was only minimally increased in relB / 
mice (Fig. 2). As the CD8  NK-1.1  subset is unrelated to
thymus-dependent CD4  NKT cells (12), this result indi-
cates a specific requirement of NF- B for the development
of V 14i NKT cells rather than for the total NK-1.1  T
cell population.
Differential Requirement of Distinct NF- B Complexes in
Hematopoietic and Radiation-resistant Stromal Cells for NKT
Cell Development. Thymic NKT cells are positively se-
lected via the interaction of their V 14-J 18 TCR with
CD1d on DP cortical thymocytes (6) but stromal compo-
nents are also required for normal NKT cell development
(22). Flow cytometric analysis revealed normal CD1d
levels on thymocytes from relB / , nfkb1 / , nfkb2 / ,
and mI B tg mice, indicating that NF- B is not required
for the expression of CD1d (unpublished data). Next, we
examined the requirement of individual NF- B members
in both hematopoietic and nonhematopoietic cells by ra-
diation chimera analysis. Reciprocal BM transplantations
between wild-type and relB /  mice revealed that RelB
in radiation resistant stromal components was required for
NKT cell development, as wild-type BM transferred into
Figure 1. Reduced numbers of thymic NKT cells in NF- B–deficient
mice. Thymocytes from adult wild-type, nfkb1 / , nfkb2 / , and relB / 
(A) as well as from control and mI B tg mice (B) were analyzed for
NK-1.1 and TCR  expression by flow cytometry. Percentages of NKT
cells (circles) were increased by gating on HSAneg-low cells. Numbers indi-
cate mean values   SD from 5–7 mice. (C) RT-PCR analysis of V 14-
J 18 expression in wild-type, mI B tg, and relB /  mice. Expression of
the C  chain is shown as an amplification control.T
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1616 Regulation of NKT Cell Development by NF- B
lethally irradiated relB /  recipients resulted in severely
impaired development of NKT cells (Fig. 3 A). RelB ap-
peared to play a minor role in hematopoietic cells, as
adoptive transfers of relB /  BM into wild-type recipients
resulted only in a 1.5-fold reduction of NKT cell num-
bers compared with controls. Interestingly, reciprocal
BM transfers between wild-type and nfkb1 /  mice re-
vealed that p50/NF- B1 was required in hematopoietic
cells rather than in the stromal compartment (Fig. 3 A).
In contrast to p50/NF- B1 but similar to RelB, p52/
NF- B2 was required in radiation-resistant nonhemato-
poietic cells for proper NKT cell development (unpub-
lished data).
To determine whether the reduced numbers of NKT
cells in mI B tg mice was a direct effect of blocking the
NF- B pathway in NKT precursors or due to the lack of
NF- B in accessory thymocytes, mixed chimeric mice
were generated. BM cells from Ly-5.1 wild-type and Ly-
5.2 mI B tg mice were mixed and injected into lethally ir-
radiated Ly-5.2 wild-type recipients. Flow cytometric
analysis showed that  70% of the thymocytes were de-
rived from Ly-5.2 mI B tg BM whereas the Ly-5.1 wild-
type BM contributed the remaining 30% (Fig. 3 B). While
only Ly-5.1 wild-type BM resulted in the generation of
NKT cells, BM from Ly-5.2 mI B tg mice was unable to
efficiently generate NKT cells despite the coexistence of
wild-type thymocytes (Fig. 3 B). Together, these data in-
dicate that thymic NKT cell development is dependent on
both RelB in the nonhematopoietic compartment and, in
a cell-autonomous manner, on classical NF- B activity in
NKT precursors.
RelB Is Required for Normal Thymic IL-15 mRNA Expres-
sion. As NF- B regulates gene expression we analyzed
total thymus steady-state mRNA levels of several genes
that have been shown to be crucial for NKT cell develop-
ment (14). Focusing on relB /  and mI B tg mice, we did
not observe significant defects in the expression of cathep-
sin S, cathepsin L, Ets-1, Fyn, GM-CSFR , IL-15R ,
IRF-1, LT , LT , and Vav-1 compared with wild-type
controls (unpublished data). In contrast, steady-state levels
of IL-15 mRNA were reduced  3-fold in relB /  but not
in mI B tg thymus (Fig. 4). IL-15 expression was not de-
tected in thymocyte single cell suspensions (unpublished
data), indicating that RelB in stromal cells is required for
the maintenance of normal IL-15 levels.
Figure 2. Selective loss of peripheral CD4  NKT cells in relB /  and
nfkb1 /  mice. NKT cells from adult wild-type, nfkb1 / , and relB / 
spleens were analyzed for CD4 and CD8 expression by flow cytometry.
Histograms show CD4 (left) and CD8 (right) expression levels on NK-
1.1 TCR   cells. Note the reduction of CD4  NKT cells in nfkb1 / 
and relB /  mice and the increase of CD8  NK-1.1  T cells in nfkb1 / 
but not in relB /  animals. Numbers indicate mean values   SD from
3–7 mice.
Figure 3. Analysis of NKT cell development in BM chimeras. (A)
Thymocytes were isolated from lethally irradiated mice that were recon-
stituted with BM as indicated (donor BM →  irradiated recipient).
HSAneg-low cells were analyzed for NK-1.1 and TCR  expression by flow
cytometry. Percentages of NKT cells (mean values from 3–7 mice   SD)
are indicated. (B) Competitive BM chimeras were generated by mixing
wild-type Ly-5.1 with mI B tg Ly-5.2 BM to reconstitute lethally irradi-
ated wild-type Ly-5.2 mice. Chimerism was checked by flow cytometry
(left). Thymocytes derived from wild-type (Ly-5.1 ) and from mI B tg
(Ly-5.2 ) BM were stained for NK-1.1 and TCR  expression and ana-
lyzed by flow cytometry (right). Percentages of NKT cells among total
thymocytes (mean values from 2–3 mice   SD) are indicated.T
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1617 Sivakumar et al.
DNA Binding of RelB Complexes Is Defective in Thymus of
aly/aly Mice. NIK is a key player in LT signaling and it
has previously been shown that NIK is required in nonhe-
matopoietic cells for normal NKT cell development (22).
As thymic NKT cell development was also dependent on
stromal RelB expression we analyzed whether the lack of
functional NIK affects constitutive DNA-binding of RelB
complexes in thymus. When whole thymus extracts were
analyzed in EMSAs a marked reduction of RelB  B-bind-
ing (complex II) was observed in aly/aly extracts and to a
lesser extent also in ltbr /  mice, whereas binding of RelA
(complex I) was not affected (Fig. 5 A). Extracts from relB / 
and tnfr1 /  mice were included as a specificity control.
To address whether NIK is also required for the induced
binding of RelB complexes we stimulated fibroblasts with
agonistic anti-LT R mAb. LT R activation in wild-type
MEFs resulted in the rapid induction of RelA (complex I)
and at later time points also RelB (complex II), while no
binding of RelB complexes could be detected in aly/aly
MEFs despite normal induction of RelA (Fig. 5 B). Thus,
both constitutive and surface receptor-induced RelB  B-
binding requires functional NIK, whereas binding of classi-
cal RelA NF- B complexes is independent of this kinase.
Lack of RelB and NF- B Blocks Early NKT Cell Develop-
ment at Different Steps. Recent evidence indicates that
NK-1.1  NKT precursors that bind to CD1d tetramers
give rise to mature NK-1.1  tetramer  cells in both thy-
mus and peripheral lymphoid tissues (15, 44, 45). As the
frequency of NK-1.1  precursors is low in adult compared
with young animals, we analyzed 2-wk-old mice by flow
cytometry. Staining of wild-type thymocytes with  -Gal-
Cer–loaded CD1d tetramer and anti-NK-1.1 mAb re-
vealed that tetramer  cells at this age consisted predomi-
nantly of NK-1.1  precursors and a smaller portion of
mature NK-1.1  NKT cells. In contrast, the NK-1.1  pre-
cursor population was markedly reduced in relB /  mice
whereas mature NKT cells were less severely affected. On
Figure 4. Analysis of IL-15 mRNA expression in thymus from NF- B–
deficient mice. RT-PCR analysis of whole thymus RNA revealed re-
duced IL-15 steady-state mRNA levels in relB /  mice. Expression of
IL-15 in thymus from mI B tg mice was similar to controls (unpublished
data). Expression of the C  chain is shown as an amplification control.
Figure 5. LT R and NIK regulate RelB DNA-binding
in thymus. (A) Whole thymus extracts from wild-type,
relB / , aly/aly, ltbr / , and tnfr1 /  mice were prepared
and analyzed for  B-binding activity in EMSAs. Com-
plexes are indicated by arrowheads and their identity was
determined with Abs specific for individual Rel/NF- B
family members. p.i., preimmune serum; complex I, RelA
heterodimers; complex II, RelB heterodimers. Complex
III consists of p50 homodimers (unpublished data). (B)
LT R-mediated induction of RelB is dependent on NIK.
Primary MEFs from wild-type and aly/aly mice were ei-
ther left untreated (un) or treated for 1 and 5 h with anti-
LT R mAb and nuclear extracts were analyzed for  B-
binding. Complexes were identified with specific Abs.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
1618 Regulation of NKT Cell Development by NF- B
the other hand, mI B tg mice had a normal NK-1.1  pre-
cursor frequency but a ninefold reduction in the percentage
of mature NK-1.1  tetramer  NKT cells (Fig. 6 A). An-
nexin V staining of thymocytes from 2-wk-old mice did
not reveal increased apoptosis of tetramer  cells in relB / 
or mI B tg mice (Fig. 6 B).
After positive selection, NKT precursors progress through
CD44lo and CD44hi stages before they become positive
for the NK-1.1 marker (for a review, see reference 14). We
therefore compared the CD44/NK-1.1 profiles of tetramer 
thymocytes in 2-wk-old wild-type, relB / , and mI B tg
mice. Whereas the percentage of mature CD44hiNK-1.1 
NKT cells was not reduced, the frequency of the in-
termediate CD44hiNK-1.1  NKT population was strongly
reduced in relB /  mice. In contrast, intermediate
CD44hiNK-1.1  NKT precursors were only mildly af-
fected in mI B tg mice, while further differentiation into
mature CD44hiNK-1.1  NKT cells was clearly impaired
(Fig. 6 C). This difference between wild-type, relB / ,
and mI B tg mice became even more obvious when
numbers of the different subpopulations were calculated
(Fig. 6 D). Fig. 6 D also shows that RelB is required for
the generation of normal numbers of early CD44loNK-
1.1  NKT precursors, whereas this population is not re-
duced in mI B tg mice. Our data indicate that these early
but distinct blocks caused by the lack of RelB in stromal
and classical NF- B in hematopoietic cells, respectively,
result in severely reduced numbers of mature V 14i NKT
cells in adult mice.
Discussion
This study reveals distinct nonredundant roles for the
NF- B family members p50/NF- B1, p52/NF- B2, and
RelB in both hematopoietic and nonhematopoietic cells
for the development of thymic NKT cells. While p50/NF-
 B1 is required in hematopoietic cells, RelB is required in
the nonhematopoietic compartment. Interestingly, the lack
of RelB in radiation-resistant stromal cells results in a more
severe decrease in NKT cell numbers than blocking total
NF- B function via the nondegradable mI B  inhibitor in
NKT precursors. CD4  NKT cells are thymus-dependent
(11, 12) and because this subpopulation is also reduced in
nfkb1 / , relB / , and mI B tg spleen it is unlikely that the
reduced numbers of thymic NKT cells is due to increased
emigration from thymus. The selective loss of these cells is
accompanied by an increase in CD8  NK-1.1  T cells in
the spleen of nfkb1 /  but not in relB /  mice. One possi-
ble explanation for this observation is that p50/NF- B1
prevents the expansion of CD8  NK-1.1  T cells. Alterna-
tively, the lack of p50/NF- B1 may result in the up-regu-
lation of the NK-1.1 marker on conventional CD8  T
cells (46). Due to the very low frequency, it is difficult to
analyze CD8  NKT cells and the specific increase of this
subpopulation in nfkb1 /  mice may help to study the
function and origin of CD8  NKT cells in more detail.
NKT cells are derived from a CD4 CD8  DP thymic
subset (15), suggesting that NKT cell development is simi-
lar to conventional T cells until the DP stage and that at
this stage the interaction of CD1d with the V 14-J 18
TCR triggers both positive selection and NKT lineage
commitment. As a CD1d/V 14-J 18 TCR-specific signal
regulating positive selection and/or commitment to the
Figure 6. Analysis of developmental intermediates of V 14i NKT cells
in NF- B-deficient mice. (A) Staining of thymocytes from 2-wk-old
C57BL/6 wild-type, relB / , and mI B tg mice with anti-NK-1.1 and
 -GalCer CD1d tetramer. (B) Analysis of apoptotic cells in thymus from
2-wk-old C57BL/6 wild-type, relB / , and mI B tg mice. Thymocytes
were stained with Annexin V and  -GalCer CD1d tetramer. HSAneg-low
cells in panels A and B were gated as in Fig. 1. (C) Expression of CD44
and NK-1.1 on tetramer  thymocytes from 2-wk-old wild-type, relB / ,
and mI B tg mice was determined by flow cytometric analysis. Numbers
in quadrants indicate mean values of percentages   SD from three mice.
(D) Numbers of tetramer  cells in 106 thymocytes from 2-wk-old wild-
type, relB / , and mI B tg mice based on their CD44 and NK-1.1 ex-
pression patterns.T
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NKT lineage has not been identified yet (14) it is important
to identify key factors within signaling pathways, which
regulate the development of NKT independent from con-
ventional T cells.
Functional NIK in nonhematopoietic cells is essential for
NKT cell development (22), which is consistent with the
lack of constitutive RelB DNA binding in thymus of aly/
aly mice and the stromal requirement of RelB for NKT
cell development. Both relB /  and aly/aly mice show sim-
ilar structural disorganization of the thymus (17, 35, 47)
and the marked defect in RelB DNA binding in aly/aly
thymus offers an explanation for the similarity of this phe-
notype. In contrast to aly/aly mice, thymic DNA binding
of RelB is only mildly affected in ltbr /  and normal in
tnfr1 /  mice, indicating that another receptor associated
with NIK may be involved in RelB activation, NKT cell
development, and the establishment of proper thymic ar-
chitecture. NIK is required for the processing of the NF-
 B2 p100 precursor to p52 (48, 49) and since the COOH-
terminal domain of p100 specifically inhibits RelB function
(50–52), lack of RelB DNA binding in the absence of
functional NIK most likely is due to defective processing of
the inhibitory p100 precursor. Similar to RelB, p52/NF-
 B2 is also required in stromal cells for normal NKT cell
development. This observation correlates with a stromal
requirement of both RelB and p52/NF- B2 for proper
spleen (29, 30) and Peyer’s patch development (52, 53),
emphasizing that p52-RelB rather than p50-RelB het-
erodimers are involved in the regulation of NKT cell de-
velopment, although we cannot rule out that p50-RelB
complexes also contribute.
Thymic steady-state mRNA levels of many genes that
have been demonstrated in knockout mouse models to be
important for NKT cell development are not affected in
relB /  and mI B tg mice. However, we observed a repro-
ducible reduction of IL-15 mRNA levels in thymus from
relB /  mice. This finding is consistent with a stromal
function of RelB since IL-15 produced by thymic stromal
cells has been shown to be essential for early NKT cell de-
velopment and homeostasis (54, 55). An NF- B binding
site has been reported in the IL-15 promoter (56) but it re-
mains to be shown whether RelB directly or indirectly
regulates expression of IL-15.
Recent reports indicate that committed NK-1.1  NKT
precursors are derived from a CD4 CD8  DP thymocyte
subpopulation. They proliferate and differentiate through
CD44loNK-1.1  and CD44hiNK-1.1  stages into mature
CD44hiCD4 /DN NK-1.1  NKT cells (15, 44, 45). We
did not observe a significant reduction in the frequency of
tetramer  DPhi NKT precursors in 12-d-old relB /  and
mI B tg mice (unpublished data), indicating that NF- B
is not required for the rearrangement of the V 14-J 18
TCR. As expression of CD1d is normal in relB /  and
mI B tg mice, it is unlikely that initial positive selection is
impaired in these mice. The analysis of 2-wk-old mice re-
vealed, however, that RelB function is required for the
generation of normal numbers of early CD44loNK-1.1 
NKT precursors, indicating that RelB in stromal cells reg-
ulates maturation/expansion of positively selected V 14i
NKT precursors. We also observed markedly reduced per-
centages and numbers of CD44hiNK-1.1  NKT precur-
sors in thymus from 2-wk-old relB /  mice. This can be
explained by an impaired transition from the CD44lo to
the CD44hi stage, which is supported by the analysis of
6-wk-old mice (unpublished data), but normal progression
from the CD44hiNK-1.1  to the mature CD44hiNK-1.1 
stage (see also Fig. 7). Interestingly, IL-15–deficient mice
also show an early block in NKT cell development (55)
and the reduced IL-15 expression in relB /  thymus may
contribute to the reduced NKT cell numbers in RelB-
deficient mice. Analysis of mI B tg mice, on the other hand,
revealed that classical NF- B function within NKT pre-
cursors is dispensable for the early generation of tetramer 
NK-1.1  cells, whereas it is required at a later step of
NKT cell development. In particular, the progression
from CD44hiNK-1.1  to the mature CD44hiNK-1.1 
stage is impaired with a milder block at the CD44lo to
CD44hi transition (Fig. 7). It is unlikely that the blocks in
NKT cell development are due to increased apoptosis
since we did not observe increased Annexin V staining of
tetramer  cells in relB /  and mI B tg mice compared
with wild-type controls.
Our results demonstrate a distinct involvement of dif-
ferent NF- B subunits in the development of NKT cells
with an important role of the classical NF- B pathway
within NKT precursor cells, while the alternative NIK/
NF- B2/RelB pathway operates in the thymic stroma.
The identification of stromal cell–derived factor(s) regu-
lated by RelB and hematopoietic cell–derived factor(s)
regulated by classical NF- B would help to better define
the role of NF- B in the regulation of different stages of
NKT cell development.
Figure 7. Model of NF- B-regulated V 14i NKT cell
development in thymus. Lack of RelB in stromal cells re-
sults in impaired generation of CD44loNK-1.1  precur-
sors. Blocking NF- B in precursors results in impaired
expansion of NKT cells predominantly at the NK-1.1  to
NK-1.1  transition. For more details see Discussion.T
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